In vertebrates, BMP signaling before gastrulation suppresses neural development. Later in development, BMP signaling specifies a dorsal and ventral fate in the forebrain and dorsal fate in the spinal cord. It is therefore possible that a change in the competence of the ectoderm to respond to BMP signaling occurs at some point in development. We report that exposure of the anterior neural plate to BMP4 before gastrulation causes suppression of all neural markers tested. To determine the effects of BMP4 after gastrulation, we misexpressed BMP4 using a Pax-6 promoter fragment in transgenic frog embryos and implanted beads soaked in BMP4 in the anterior neural plate. Suppression of most anterior neural markers was observed. We conclude that most neural genes continue to require suppression of BMP signaling into the neurula stages. Additionally, we report that BMP4 and BMP7 are abundantly expressed in the prechordal mesoderm of the neurula stage embryo. This poses the paradox of how the expression of most neural genes is maintained if they can be inhibited by BMP signaling. We show that at least one gene in the anterior neural plate suppresses the response of the ectoderm to BMP signaling. We propose that the suppressive effect of BMP signaling on the expression of neural genes coupled with localized suppressors of BMP signaling result in the fine-tuning of gene expression in the anterior neural plate.
INTRODUCTION
Bone morphogenetic protein 4 (BMP4), a member of the TGF␤ family of growth factors, and other members of the BMP signaling pathway play multiple roles in the development of the central and peripheral nervous system. In the frog, BMP4 signaling before gastrulation suppresses neural and promotes epidermal cell fates (Wilson and HemmatiBrivanlou, 1995; Sasai et al., 1995; reviewed in Weinstein and Hemmati-Brivanlou, 1999) . Conversely, neural ectoderm is induced by the absence of BMP signaling. Follistatin, noggin, chordin, cerberus, and Xnr3, secreted by the organizer, are all able to block BMP activity and have neural-inducing ability (Hemmati-Brivanlou et al., 1994; Hemmati-Brivanlou and Melton, 1997; Sasai et al., 1995; Lamb et al., 1993; Smith and Harland, 1992; Piccolo et al., 1996; Zimmerman et al., 1996; Bouwmeester et al., 1996; Iemura et al., 1998) . Although in chick some BMP inhibitors are not sufficient to induce a neural fate (Streit et al., 1998) , in all vertebrates neural induction is correlated with loss of BMP signaling from the ectoderm before and during gastrulation (reviewed in Harland, 2000) .
Later in development, after neural tube closure, BMP signaling has a role in patterning along the dorsoventral axis. In chick, mouse, and zebrafish, BMP signaling emanating from the dorsal epidermal ectoderm and the dorsal neural tube establishes the differentiation of neural crest (LaBonne and Bronner-Fraser, 1998; Selleck et al., 1998; Marchant et al., 1998) , as well as dorsal interneuron differentiation, while limiting the extent of ventral interneuron differentiation (Dickinson et al., 1995; Liem et al., 1995 Liem et al., , 1997 Hogan, 1996; Lee et al., 1998; Nguyen et al., 2000) . The BMP antagonists chordin, noggin, and follistatin are expressed in the notochord and floorplate (Smith and Harland, 1992; Sasai et al., 1994; Dale et al., 1999; Liem et al., 2000) and are suggested to refine the dorsoventral patterning of the spinal cord by attenuating BMP signaling (McMahon et al., 1998; Liem et al., 2000) .
BMP signaling also plays a role in specifying the dorsoventral axis of more rostral regions of the CNS (Graham et al., 1994; Arkell and Beddington, 1997; Shimamura and Rubenstein, 1997) . In the mouse and chick forebrain, overexpression of BMPs by bead implantation causes loss of ventral and maintenance of dorsal forebrain markers (Furuta et al., 1997; Golden et al., 1999) . In addition, the combined action of BMP and Shh signaling specifies the most rostral region of the ventral forebrain, the hypothalamus, while Shh alone specifies more posterior ventral tissue (Dale et al., 1997 (Dale et al., , 1999 . In later stages of cerebral cortical development, BMPs promote neuronal and astroglial differentiation and inhibit oligodendroglial differentiation (Mabie et al., 1999; Mehler et al., 2000) , suggesting a role in selectively regulating populations of progenitor cells and brain morphogenesis.
These diverse roles of BMP signaling in neural development are reflected in the dynamic expression pattern of BMPs during development. In the late gastrula and early neurula, BMP4 expression is limited to the epidermal ectoderm, flanking the neural plate (Streit and Stern, 1999) . However, once the neural tube has closed, BMP expression persists in the roof plate, dorsal neural tube (Jones et al., 1991; Liem et al., 1995 Liem et al., , 1997 Lyons et al., 1995; Arkell and Beddington, 1997; Dudley and Robertson, 1997) , and in discrete regions of the fore-, mid-, and hindbrain (Jones et al., 1991; Dudley et al., 1995; Furuta et al., 1997; Arkell and Beddington, 1997; Golden et al., 1999) . In the chick, BMP4 and BMP7 are also expressed in prechordal mesoderm (Dale et al., 1997; Vesque et al., 2000) .
In summary, there is evidence that BMPs have antineural activity during gastrulation stages but there is also evidence that they are positively involved in imparting dorsalventral patterning information throughout the CNS. Studies on the dorsoventral patterning role of BMP have focused on late stages of development; therefore, it is possible that, during the course of development, some neuroectodermal genes change from a negative to a positive response to BMP signaling. This view is challenged by work in zebrafish, which showed that BMP signaling is required for specification of neurons at all dorsoventral positions at the neural plate stage (Barth et al., 1999 ; see also Neave et al., 1997) . However, this may reflect a postgastrulation requirement for BMP4 signaling. Therefore, it is not clear whether and when a change in response of ectodermal cells to BMP signaling takes place.
In this study we aim to address this question directly by using gain-of-function approaches in Xenopus embryos. First, we characterized the response of the ectoderm to BMP signaling before gastrulation using a panel of neural markers. Then, we used the REMI transgenesis technique to express BMP4 throughout the developing anterior neural plate from the end of gastrulation under the control of the Xenopus Pax-6 promoter. We report that, contrary to our expectations, the response to BMP4 did not differ significantly before and after gastrulation. During the neurula stages, BMP4 continued to function as an inhibitor of the majority of genes expressed into the anterior neural plate. These findings were confirmed by implanting BMP4 beads into the anterior neural plate during the neurula stages. However, we found two genes that showed a difference in sensitivity to BMP4 signaling before versus after gastrulation. One of these genes was the pan-neural gene nrp1, which was sensitive to early BMP4 signaling but resistant after gastrulation. The other gene was X-dll3, expressed in the anterior border of the neural plate. Early BMP4 signaling inhibited the expression of this gene in the anterior region of the embryo, although BMP4 signaling after gastrulation resulted in a significant increase in expression in this region of the embryo. We also found that at the same stages, both BMP4 and BMP7 are expressed in cells of the anterior mesendoderm. This poses a paradox of how the neural plate develops, given that, based on our findings, exposure of neural plate cells to BMP signaling should result in suppression of most neural gene expression. However, we also found that the anterior neural plate expresses localized inhibitors of BMP expression and signaling. Therefore, to reconcile these observations, we propose a model whereby expression of BMPs from the prechordal mesoderm along with localized BMP inhibitors in the neural plate contribute to the fine-tuning of neural gene expression in the rostral neural plate.
MATERIALS AND METHODS

BMP4 mRNA Injections
One dorsal blastomere of 4-to 8-cell embryos was injected with 200 pg of capped synthetic BMP4 RNA, along with lacZ RNA, which serves as a lineage marker. At the neural plate stage, embryos were fixed and stained with X-gal as described (Bourguignon et al., 1998) , to reveal the distribution of the injected RNAs. The embryos were then analyzed by whole-mount in situ hybridization (see below) and compared to uninjected control embryos that had undergone the same postfixative treatment as the injected embryos. BMP4 RNA was transcribed in vitro using T3 polymerase from a BMP4 template (kindly provided by Dr. Eddy De Robertis) after linearization with XhoI.
Whole-Mount in Situ Hybridizations
Whole-mount in situ hybridizations were performed following the protocol of Harland (1991) . Antisense riboprobes were labeled with digoxigenin-11-UTP (Roche Molecular Biochemicals, Indianapolis, IN) and visualized using BCIP (X-phosphate/5-bromo-4-chloro-3-indolyl phosphate; Roche) and NBT (nitro blue tetrazolium; Sigma, St. Louis, MO). Double in situ hybridization was performed according to a protocol developed by Dr. T. Doniach and described in Knecht et al. (1995) . The substrates for the reaction were 5-bromo-6-chloro-3-indolyl phosphate (Molecular Probes, Eugene, OR) for the first chromogenic reaction and BCIP for the second reaction. After whole-mount in situ hybridization, embryos were stored and photographed in MEMFA. Probes were generated from the following plasmids, linearized with the indicated restriction enzymes and transcribed with the indicated RNA polymerase: BMP4, EcoRI, T7 polymerase (Fainsod et al., 1994) ; BMP-7, XhoI, T3 polymerase (Wang et al., 1997) ; CSGFP3, BamHI, T7 polymerase (Bronchain et al., 1999) ; XBF-1, ClaI, T7 polymerase (Bourguignon et al., 1998) ; Xotx2, NotI, T7 polymerase (Lamb et al., 1993) ; T7TS-XSox3, SmaI, T7 polymerase (Zygar et al., 1998) ; X-dll3, NotI, T7 polymerase (Papalopulu and Kintner, 1993) ; XBF-2, EcoRI, T7 polymerase (Gomez-Skarmeta et al., 1999) ; Xenopus Pax-6, EcoRI, SP6 polymerase (Hirsch and Harris, 1997) ; Xrx1, BamHI, T7 polymerase (Andreazzoli et al., 1999) ; nrp1, BamHI, T3 polymerase (Richter et al., 1988) ; and Msx1, EcoRI, T3 polymerase .
Isolation of the Pax-6 Promoter
A 2 ϫ 10 6 pfu sample of a lambda Dash BamHI partial Xenopus laevis genomic library (Leroy and De Robertis, 1992 ) was screened at high stringency with a 500-bp EcoRI probe from the 5Ј end of Pax-6 cDNA (Hirsch and Harris, 1997) . Three clones were isolated and these were further screened using a 200-bp BamHI-SacI fragment of the 5Ј UTR of Pax-6 cDNA. Lambda DNA preps (as described in Sambrook et al., 1989) were performed on two isolated plaques from a third screen. These clones contained 17.4 kb of identical genomic DNA, which was found to contain the first three exons of Pax-6, as well as 12 kb of the untranscribed 5Ј sequence. EcoRI fragments of this 17.4-kb DNA were subcloned into pBluescript II KS and Southern blots were carried out to find the sequence lying 5Ј to the Pax-6 cDNA. A 7-kb EcoRI fragment hybridized to the 200-bp Pax-6 probe and contained 3.6 kb of the 5Ј untranscribed sequence, 400 bp of exon 1 [corresponding to the 5Ј region of Pax-6 cDNA isolated by Li et al. (1997)] , and 3 kb of the intron 1 sequence. The 3.6-kb EcoRI-HindIII fragment was identified as the Pax-6 promoter and sequencing was undertaken on both strands of this 3.6-kb genomic fragment. GenBank accession number AY048575.
Transgenic Misexpression of GFP and BMP4
The 3.6-kb EcoRI-HindIII Pax-6 genomic fragment was subcloned in front of an enhanced version of GFP (Zernicka-Goetz et al., 1996) . This construct was then termed Pax-6GFP. The same genomic fragment was subcloned 5Ј to BMP4. This construct was termed Pax-6BMP4. Both constructs contain a 5Ј ␤-globin UTR and SV40 poly A sequence 3Ј to the coding region.
Generation of transgenic Xenopus laevis embryos was carried out according to Kroll and Amaya (1996) , with the following exceptions: 100 ng of Pax-6GFP, or Pax-6BMP4, cut with Asp718 was cointegrated with 100 ng of CSGFP3 (containing the enhanced version of GFP under the control of the sCMV IE94 promoter) (Bronchain et al., 1999) , also cut with Asp718 into 1 ϫ 10 6 sperm nuclei, decondensed with 4 l of high-speed interphase egg extract, containing 1 unit of Asp718 in a total volume of 25 l. Following a 15-min incubation at room temperature the nuclei were diluted and transplanted into dejellied unfertilized eggs. Embryos were screened at the 4-cell stage and cultured in 0.1ϫ MMR, 6% Ficoll, and 20 g/ml gentamycin until the end of gastrulation. Embryos were then transferred into 0.1ϫ MMR and screened at stages 15-17 for expression of GFP under a fluorescent dissecting microscope. Staging of embryos was according to Nieuwkoop and Faber (1967) .
After in situ hybridization to various marker genes, embryos expressing BMP4 under the control of the Pax-6 promoter were compared to embryos expressing GFP under the control of the Pax-6 promoter. The expression pattern of the marker gene was assessed as being either unchanged, increased (in intensity or domain of expression), decreased (in intensity or domain of expression), or absent, by direct comparison to a control embryo (Pax-6GFP) with wild type marker gene expression.
Cointegration of Transgenes
To test the percentage of cointegration of two different transgenes in embryos, 100 ng of the Xenopus laevis ␥1crystallin promoter driving GFP3 (CryGFP3) (Bronchain et al., 1999) , linearized with NotI, was mixed with 100 ng of either Pax-6GFP or Cardiac Actin promoter driving GFP3 (XCarGFP) (Breckenridge et al., 2001) , both linearized with NotI. Additionally, 100 ng of the CMV promoter driving RFP [CMVRFP, constructed by removing RFP from dsRed (Clontech, Palo Alto, CA) with PinA1 and Bfr1 (end-filled) and ligating to PCS2ϩ, linearized with BamHI (endfilled) and linearized with Asp718] was mixed with 100 ng of Pax-6GFP, linearized with Asp718. These mixtures were then used in REMI transgenesis and the resulting embryos scored at stage 30 by fluorescence microscopy.
Sectioning of Embryos
Embryos, selected for sectioning after whole-mount in situ hybridization, were soaked in 2 ml of a gelatin-albumin mixture for 10 min before being embedded in a total of 4 ml of gelatinalbumin, which was fixed by the addition of glutaraldehyde. Embedded embryos were cut into blocks, mounted, and sectioned at 20 -25 micron thicknesses on a Leica VT1000M vibratone, mounted in 90% glycerol, and photographed.
BMP4 Bead Implantation
Affi gel Blue gel agarose beads (Bio-Rad, Richmond, CA) were rinsed three times in 1ϫ PBS and dehydrated completely. Beads were then soaked in 100 g/ml of Human BMP4 (R&D Systems, Minneapolis, MN), which was made up in 1ϫ PBS with 0.1% BSA. Control agarose beads were soaked in 1ϫ PBS/0.1% BSA. Beads were implanted into the rostral neural plate at different stages in 0.1ϫ MMR. Embryos were then cultured until stage 16 or later, fixed in MEMFA for 1 h, and stored in ethanol at Ϫ20°C prior to in situ hybridization.
RESULTS
Injection of BMP4 RNA
To evaluate a potential change in the response of ectodermal cells to BMP4 before and after gastrulation, we first characterized in detail the effects of BMP4 RNA injection at the 4-to 8-cell stage. The phenotype of BMP4 RNA-injected embryos ranged from a reduced to entirely absent neural plate. We analyzed the expression of the regional neural markers Xotx2, XBF-1, XBF-2, Xrx1, XSox3, and Pax-6, and the pan-neural marker nrp1. We found that all genes were reduced both in their level of expression and in the extent of the expression domain (Fig. 1 , data not shown). X-dll3, which marks the boundary of the anterior neural plate, showed a reduction in the level and circumference of its expression (Fig. 1) .
These findings confirm and extend previous work showing that early exposure of ectoderm to BMP4, its downstream target gene Msx1, or its signal transducer smad1, inhibits neural fate as judged by the expression of NCAM (Wilson and Hemmati-Brivanlou, 1995; Suzuki et al., 1997; Wilson et al., 1997) or HairyII (Schmidt et al., 1995) .
Cloning and Sequence of the Pax-6 Promoter
To investigate the effect of BMP signaling on anterior neural plate development after gastrulation, we needed to isolate a neural plate specific promoter, which would drive the expression of BMP4 throughout this area in transgenic frog embryos after the completion of gastrulation. We chose to isolate the Pax-6 promoter because this gene is expressed throughout the anterior neural plate from the early neurula stage (stage 12.5) (Hirsch and Harris, 1997; Li et al., 1997) .
A Xenopus laevis genomic library (Leroy and De Robertis, 1992) was screened with a Xenopus Pax-6 probe containing the 5Ј UTR. One genomic clone was selected and analyzed further (see Materials and Methods). A 3.6-kb EcoRIHindIII subclone of this genomic clone was termed the Xenopus Pax-6 promoter ( Fig. 2A) . The HindIII site lies just 3 bp 5Ј to the putative transcription start, as judged by homology to the human Pax-6 promoter. A TATA-like sequence (ATATTT) is located 19 bp upstream of the HindIII site and two CCAAT boxes are located at Ϫ70 and Ϫ100 bp. There is a region of significant sequence homology between the Xenopus Pax-6 promoter and quail Pax-QNR at Ϫ1757 to Ϫ1597 bp (Fig. 2B) .
Expression of the Pax-6 Promoter Driving GFP
We examined whether the 3.6-kb Pax-6 promoter fragment recapitulated the expression pattern of the endogenous Pax-6 gene. We generated transgenic frog embryos with the Pax-6 promoter driving GFP and analyzed the expression pattern either by direct observation of GFP fluorescence or by whole-mount in situ hybridization to GFP RNA, combined with whole-mount in situ hybridization to the endogenous message (Fig. 3) . As previously described, expression of Pax-6 is first detected at the end of gastrulation/beginning of neurulation (stage 12.5) (Hirsch and Harris, 1997; Li et al., 1997) . Analysis of in situ hybridization to GFP RNA revealed that the 3.6-kb Pax-6 promoter fragment initiated expression at the same stage. We conclude that the expression driven by the Pax-6 promoter is temporally correct. In the early neurula, expression of endogenous Pax-6 is found in the anterior and posterior neural plate (Fig. 3A) . In the anterior neural plate Pax-6 is expressed in a domain that spans most of the anterior neuroectoderm. The Pax-6GFP transgene is expressed at stages 13-14 in a similar domain (Figs. 3B and 3C ). In the posterior neural plate, Pax-6 is expressed in two lateral domains that give rise to the ventral-lateral spinal cord and hindbrain. This expression is also recapitulated by the transgene, indicating that the promoter contains elements for the correct anterior and posterior expression. Normally there is a gap in expression between the anterior and posterior domains at the level of the midbrain and this is also seen with the transgene. At stage 25, the Pax-6GFP transgene continued to be expressed in a pattern similar to that of the endogenous Pax-6 gene (compare Figs. 3D and 3E) . Because of the lag in the accumulation and processing of the GFP protein, fluorescence in the Pax-6GFP transgenic embryos was not apparent until around stage 20 (Figs. 3F and 3L) .
Although the early temporal and spatial expressions of the transgene were very similar to those of the endogenous gene, we did detect some differences. During neurulation, the anterior Pax-6 expression domain is split in two by downregulation of Pax-6 in the middle (Li et al., 1997) . This medial repression does not take place with the transgene and, later on, there is higher expression in the telencephalon than endogenous Pax-6 (Figs. 3C, 3G-3K, and Fig. 4A ). This lack of medial repression may be attributed to the increased stability of the GFP RNA, although we cannot exclude the possibility that some repressor elements are lacking from the 3.6-kb promoter fragment. At stage 30, the transgene lacks strong expression in the diencephalon and The yellow box highlights a 160-bp highly conserved region with C. coturnix Pax-QNR. The 178 base pairs of DNA sequence from the 3Ј end of this fragment are shown underneath. A TATA box is located at Ϫ26 (highlighted by a black rectangle). Two CCAAT boxes are located at Ϫ70 and Ϫ100 (orange boxes). The blue box and dashed line in the sequence represent a 100% conserved region with the Human Pax-6 promoter. The solid line and green box represent highly conserved regions with Human and C. coturnix Pax-6 genomic fragments. (B) A 160-bp segment of Xenopus Pax-6 genomic sequence from Ϫ1597 to Ϫ1757 of the Pax-6 promoter (top row) aligned with sequence from C. coturnix Pax-QNR (lower row). The alignment shows 83% homology between these two Pax-6 genomic fragments.
FIG. 3.
The Pax-6 promoter drives the expression of GFP in a similar domain to that of endogenous Pax-6. Panels A, D, G, and J show images of embryos stained for endogenous Pax-6 RNA by whole-mount in situ hybridization at stages 14, 25, 30, and 32, respectively. Panels B, E, H, and K show images of Pax-6GFP transgenic embryos stained for GFP RNA by whole-mount in situ hybridization at stages 14, 25, 30, and 32, respectively. At stage 14, both endogenous Pax-6 (A) and GFP transgene (B) are expressed in a broad arc at the anterior neural plate, which gives rise to the forebrain and eyes. Expression is also apparent in two lateral stripes in the posterior neural plate that will give rise to the hindbrain and neural tube. (C) A stage 14 transgenic embryo stained for endogenous Pax-6 RNA (magenta) and GFP RNA (light blue). (I) A stage 32 half transgenic embryo stained by whole-mount in situ hybridization to Pax-6 (light blue) and GFP (magenta). Note strong expression of GFP transgene in the telencephalon (arrow). (F), (L) Fluorescence images in Pax-6GFP transgenic embryos at stages 25 and 32, respectively. in the lens, suggesting that separate elements missing from our 3.6-kb genomic fragment are required for these expression domains (Fig. 4) . We conclude that the 3.6-kb Pax-6 promoter fragment contains most of the necessary elements to drive the correct spatiotemporal expression of Pax-6 and is particularly suitable for misexpression experiments in the anterior neural plate, following gastrulation.
Two Transgenes Are Cointegrated at High Frequency
When generating transgenic frog embryos using the REMI procedure, not all resulting embryos contain the transgene. On average, around 50% of embryos are transgenic, but from experiment to experiment, this percentage can range from 20 to 80% (Kroll and Amaya, 1996) . To interpret the effect of a transgene on the expression of other genes, it is essential to be able to identify the transgenic embryos, while at the same time assaying for the expression of the gene of interest. Given that transgenes commonly integrate as large concatamers (Kroll and Amaya, 1996) , we reasoned that cointegration of two transgenes (e.g., one expressing GFP ubiquitously) could be used to easily identify the transgenic embryos. To test whether two transgenes commonly cointegrate in the REMI procedure, we generated transgenic embryos with two plasmid constructs, expressing GFP in nonoverlapping domains; CryGFP3 drives GFP expression in the lens (Fig. 5A) and XCarGFP drives expression in the somites (Fig. 5B ) of stage 35 embryos. We found that 94% of the embryos generated with both constructs expressed in both domains, when analyzed by fluorescent microscopy (Fig. 5C) . A similar frequency of coexpression was obtained by cointegrating XCarGFP and Pax-6GFP (data not shown) and also CMVRFP, expressing red fluorescent protein ubiquitously and Pax-6GFP (Fig. 5D) . We conclude that when two constructs are used in the same REMI reaction, the frequency of cointegration is very high.
Pax-6 Promoter Driving BMP4
To assess the role of BMP4 during the early neurula stages of development, transgenic Xenopus embryos were generated with the Pax-6 promoter driving either BMP4 or GFP3, cointegrated with CSGFP3. Given that CSGFP3 expresses GFP ubiquitously from the midgastrula stage, embryos were selected as transgenic at stages 15-17 based on ubiquitous GFP fluorescence.
Morphologically, expression of BMP4 in the Pax-6 domain suppressed anterior brain and eye formation in 90.7% of tailbud stage embryos, compared with 36% of GFP   FIG. 4 . Expression of endogenous Pax-6 compared with that of GFP driven by the Pax-6 promoter as seen in sagittal sections of stage 32 embryos. Top row shows in situ hybridization to GFP driven off the Pax-6 promoter and bottom row shows in situ hybridization to endogenous Pax-6 mRNA. Both the transgene and the endogenous gene are expressed in the retina (A and D) but the transgene is absent from the lens (A). The transgene also shows higher expression in the telencephalon (arrow, A) but lower expression in the diencephalon (B versus E). GFP is expressed in the hindbrain (B), in a similar domain to Pax-6 (compare B to E). Both GFP and Pax-6 are expressed in the neural tube (C and F, respectively). Abbreviations: HB, hindbrain; L, lens; Di, diencephalon; NR, neural retina. expressing embryos (Fig. 6C) . Next, we analyzed the expression of anterior neural genes that partially (Xrx1, Xotx2) or totally overlap with Pax-6 (Pax-6 itself) as well as genes that are expressed anterior (XSox3, XBF-1, X-dll3) or posterior (XSox3, Xotx2, XBF-2) to the Pax-6 expression domain. The expression of all these genes was affected, demonstrating that the effect of the Pax-6BMP4 transgene is not limited to its expression domain (Fig. 6A) . All genes were downregulated by BMP4 misexpression in the anterior neural plate, with the exception of X-dll3, which was strongly upregulated (Fig. 6A) . However, the percentage of embryos showing downregulation varied for each gene (Fig. 6B) . Xrx1, Xotx2, and XSox3 were the most strongly affected genes. Xotx2, expressed throughout the anterior neural plate (Pannese et al., 1995; Kablar et al., 1996) , was most dramatically decreased by BMP4 (98%, n ϭ 85). However, it also showed some inhibition in control embryos (38%, n ϭ 76). Although embryos with severe gastrulation defects were not included in this analysis, we believe that the high "background" inhibition in control embryos shows that Xotx2 expression is particularly sensitive to even mild perturbations of gastrulation. Surprisingly, Pax-6 was not as strongly downregulated by BMP4 misexpression as Xrx1 (33.3% vs 92.5%), even though both genes are expressed in similar expression domains.
XBF-1 and XBF-2 (also known as FoxG1 and FoxD1) (Kaestner et al., 2000) are two winged helix transcription factors (Bourguignon et al., 1998; Mariani and Harland, 1998; Gomez-Skarmeta et al., 1999) expressed just anterior and posterior to Pax-6, respectively (Z. Hardcastle and N. Papalopulu, unpublished observations). These were also reduced by BMP4 misexpression, although this reduction was not as marked as that of Xrx1 and Xotx2. XSox3, an HMG-containing transcription factor, which at this stage is expressed in two horseshoe stripes, one anterior and one posterior to Pax-6 (Penzel et al., 1997) , was also found to be FIG. 5. The cointegration of two constructs into one transgenic embryo occurs at high frequency when the same restriction enzyme is used to linearize both constructs and to cut the sperm DNA. Ninety-four percent of resulting transgenic embryos (stage 35) contained both the XCarGFP (expressing in the somites) and the CryGFP3 (expressing in the lens) transgenes (C), whereas 3% contained only the CryGFP3 transgene (A) and 3% only the XCarGFP transgene (B). Similarly, 91% of embryos in a separate experiment contained both the CMVRFP and Pax-6GFP constructs when added together in the same transgenic reaction (D).
inhibited by BMP4 expression (64.8% of embryos compared with 3.5% GFP controls).
A gene that was differentially regulated by BMP4 early versus late was the pan-neural marker nrp1 (Richter et al., 1988) . Whereas early expression of BMP4 led to a significant decrease in the level of nrp1 (Fig. 1) , late expression of BMP4 from the Pax-6 promoter did not appreciably alter its expression, suggesting that induction of neural tissue is not inhibited at this stage (Fig. 6A) .
X-dll3, the homolog of mouse Dlx5 (Stock et al., 1996) , is expressed anterior to Pax-6, on the rostral rim of the neural plate in an area that is fated to form the olfactory placodes and part of the ventral telencephalon (Papalopulu and Kintner, 1993) . On expressing BMP4 behind the Pax-6 promoter, we found that X-dll3 expression was expanded over the anterior neural plate when compared to GFP expressing controls (57% compared with 6.3% of control embryos). This was in contrast to the effect BMP4 had on X-dll3 when misexpressed early from injected RNA (Fig. 1) , which led to a marked decrease in expression in the anterior region of the embryo.
To test whether the anterior neural plate had acquired an epidermal or neural crest fate we tested the expression of keratin (Jonas et al., 1985) and Xslug (Mayor et al., 1995) , but neither gene was altered in Pax-6BMP4 transgenic embryos (data not shown). Because X-dll3 was the only gene that was upregulated in Pax-6BMP4 transgenic embryos, we conclude that part of the anterior neural plate had acquired an "anterior neural border" character.
BMP4 Beads Implanted into the Rostral Neural Plate Inhibit Anterior Neural Markers
To confirm our data produced by misexpressing BMP4 under the control of the Pax-6 promoter, we implanted agarose beads presoaked in BMP4 protein into the rostral neural plate of stage 13 embryos and analyzed the embryos at stages 16 -17. Like the Pax-6BMP4 transgene, BMP4 beads had long-range effects on gene expression. The results from bead implantations confirmed the inhibition of the same neural markers by BMP4 at this stage of development (Fig. 7A) . BMP4 beads also confirmed the differential sensitivity of anterior genes to BMP4. For example, simultaneous analysis of XSox3 and Pax-6 showed that Pax-6 was far less sensitive than XSox3 to BMP4 inhibition (Fig. 7A) . Also, the expression of XBF-2 was less affected than other markers by implantation of BMP4 beads (Fig. 7A) . As was the case in the transgenic Pax-6BMP4 embryos, X-dll3 was upregulated by the implantation of BMP4 beads into the anterior neural plate (P. Day and N. Papalopulu, unpublished observations), as is also the case in the chick (Pera et al., 1999) . In addition, nrp1 expression was not significantly affected by BMP4 bead implantation at stage 13, stage 16, or stage 20 (Fig. 7B) . However, in the same embryos, the expression of XSox3 continued to be downregulated throughout the neurula stages (Fig. 7B ).
BMP4 and BMP7 Are Expressed in the Prechordal Mesoderm Underlying the Neural Plate
We then assessed whether anterior neuroectoderm might normally be exposed to BMP signals at the neural plate stage. As a first measure of this we determined the expression pattern of BMP4 and BMP7 in the anterior regions of neurula stage embryos. We found that BMP4 is expressed strongly just anterior to the neural plate and weakly at its lateral edges, leaving a keyhole-shaped area corresponding to the neural plate free from BMP4 (Fig. 8A) . Sections revealed that BMP4 is expressed in the nonneural ectoderm, up to the boundary with the anterior neural plate (Fig. 8B) . In addition, a high level of expression was observed in the prechordal mesoderm, which underlies the rostralmost neural plate (Figs. 8B and 8C ). BMP7 was also expressed in the prechordal mesoderm (Fig. 8D) . Expression of both molecules was particularly strong in the region underlying the medial part of the anterior neural plate, tapering off to the lateral sides (data not shown).
XBF-1 Suppresses the Response of the Ectoderm to BMP4
Next, we tested the ability of one anterior neural gene, XBF-1, to interfere with BMP4 signaling. We imagined that
FIG. 6. (A)
The expression of BMP4 behind the Pax-6 promoter inhibits most neural markers at early neurula stages of development. Left-hand column: embryos transgenic with Pax-6GFP (controls); right-hand column: embryos transgenic with Pax-6BMP4. All the embryos shown are also transgenic for CSGFP3 (as observed at stage 15 by fluorescence microscopy). Embryos were fixed between stages 15 and 19 and stained by whole-mount in situ hybridization to the neural plate markers listed on the left. A reduction in Xotx2, Xrx1, XSox3, and XBF-1 expression and, to some extent, a reduction in XBF-2 and Pax-6 expression was seen in Pax-6BMP4 transgenic embryos. In contrast, the expression of the pan-neural marker nrp1 was not significantly affected by the Pax-6BMP4 transgene, whereas X-dll3 was significantly expanded into the anterior neural plate by the Pax-6BMP4 transgene. Bottom panels show cross sections of the anterior neural region of Pax-6GFP control (left) and Pax-6BMP4 (right) transgenic embryos stained for X-dll3. such interference might protect some anterior neural genes from the negative effects of BMP4 signaling. Indeed, we found that XBF-1 interferes with BMP4 signaling at two levels. First, injections of XBF-1 in whole embryos suppressed BMP4 expression over the injected area (Fig. 9A) . Second, implanting BMP4-soaked beads in XBF-1 expressing animal caps blocks their response of an immediate early gene to BMP4. Animal caps express a basal level of msx- 1   FIG. 7. (A) BMP4 misexpression by bead implantation into the anterior neural plate of stages 13-14 embryos results in the suppression of most neural markers. Left column shows embryos implanted with control, BSA beads in the anterior neural plate. Embryos were fixed at stage 17 and stained by in situ hybridization to the range of neural markers on the left. Right column shows embryos implanted with beads soaked in BMP4 in the anterior neural plate. Suppression of the neural markers listed on the left can be seen in the vicinity of the bead, with the exception of Pax-6, which remained unchanged. Pax-6 was analyzed by double in situ hybridization with XSox3, where XSox3 expression is shown in light blue and Pax-6 in magenta. Note that, while the XSox3 gene was downregulated (i.e., absence of blue stain), Pax-6 expression remains (i.e., presence of magenta stain) in the anterior right neural plate, where the bead was implanted. (B) Suppression of XSox3 (light blue) is also observed when BMP4 beads are implanted at stages 16 and 20 and analyzed at stages 19 and 25, respectively. Bead implantation at stage 13 is shown for comparison. These embryos were analyzed by double in situ hybridization to XSox3 (light blue) and nrp1 (light magenta). Expression of nrp1 is not affected by BMP4 bead implantation throughout the neurula stages (right panel). Note retention of magenta stain (i.e., nrp1 expression), but a significant reduction in light blue stain (i.e., XSox3 expression) in embryos on the right. Embryos implanted with control BSA beads are shown on the left and have no affect on either nrp1 or XSox3. and this expression is further stimulated by the addition of BMP4 (Fig. 9B) . When animal caps were harvested from embryos injected with XBF-1 RNA they did not express msx1 in response to BMP4 beads (Fig. 9B) . Thus, ectoderm expressing XBF-1 is unable not only to make BMP4 RNA but also to respond to BMP4 signaling.
DISCUSSION
Competence is defined as an intrinsic cell state that determines the response of a tissue to an inducing signal. Change in competence over time is a recurrent mechanism in development, which modifies the response of a tissue to the same signal during embryogenesis. Indeed, there are several well-known examples where cells change their competence to respond to a factor during development. For example, embryonic ectoderm autonomously loses its competence to respond to mesoderm inducers at the late blastula stage (Grainger and Gurdon, 1989) , while still retaining competence to respond to neural inducers (reviewed in Harland, 1994) .
During development, exposure of ectodermal cells to BMP4 before gastrulation potently inhibits neural development (Wilson and Hemmati-Brivanlou, 1995) . However, at later stages, BMP4 has a positive rather than a negative effect on some aspects of neural development. For example, at neural tube stages, BMP signaling promotes a dorsal midline fate (Dickinson et al., 1995; Liem et al., 1995 Liem et al., , 1997 Hogan, 1996; Furuta et al., 1997; Lee et al., 1998; Nguyen et al., 2000) and in cooperation with shh, induces a ventral midline fate in the developing forebrain (Dale et al., 1997) . These findings can be explained by a change in the competence of ectodermal cells to BMP signaling.
The aim of this work was to determine whether genes expressed in the anterior neural plate change their responsiveness to BMP4 signaling during the neurula stages. We reasoned that this information is an important prerequisite for any study aiming to understand the molecular mecha- nisms by which cells change their competence to BMP signaling. With the exception of one gene (nrp1), all genes examined are transcription factors and are therefore likely to have a regulatory role.
To answer this question, we exposed neuroectodermal cells to BMP4, starting at the blastula stages following BMP4 RNA injection, and compared the results with those obtained by misexpressing BMP4 after the end of gastrulation. This late misexpression was achieved by two methods. First, we cloned and characterized the promoter of Pax-6, a gene expressed in the anterior neural plate from stage 13 onward. We used this promoter to drive the expression of BMP4 in transgenic Xenopus embryos. Second, we implanted BMP4-soaked beads in the anterior neuroepithelium starting at stages 13-14.
Both late misexpression methods gave essentially the same results and our main conclusions can be summarized as follows: First, the expression of most anterior neuralplate genes was reduced. This included genes that overlap with Pax-6 as well as genes that are located anterior or posterior to Pax-6. Two exceptions to this rule were nrp1, a pan-neural marker that ceased to be sensitive to BMP4 after gastrulation, and the other was X-dll3, an anterior neural edge marker that was upregulated by late exposure to BMP4 but suppressed by early exposure. Second, among the genes that were reduced in response to BMP4 signaling there was considerable variation to the degree of inhibition. For example, Xrx1 and Xotx2 were very sensitive, whereas XBF-2 and Pax-6 were less sensitive, to BMP4 misexpression.
This widespread suppression of neural markers was unexpected because several lines of evidence suggest that neural induction takes place during gastrulation. Indeed, the expression of BMP antagonists on the dorsal side of the embryo is initiated at the late blastula to early gastrula stages (Lamb et al., 1993; Sasai et al., 1994 Sasai et al., , 1995 HemmatiBrivanlou et al., 1994) and several neural markers are turned on in the ectoderm soon after (Pannese et al., 1995; Ma et al., 1996; Penzel et al., 1997) . In fact, recent findings in the chick suggest that neural induction is initiated before gastrulation (Wilson et al., 2000; Streit et al., 2000) and that by the late gastrula stages, neural cells are refractory to the repressing activity of BMP4 (Wilson et al., 2000) . Explant studies in zebrafish showed that the neuroectodermal fate is specified by the early gastrula stage (Grinblat et al., 1998) . When gastrulation is complete, the neural plate is morphologically distinct from adjacent tissues.
Regionalization also takes place during gastrulation, in that both widespread and regionalized neural gene expression is in place at the neurula stage. Finally, several reports have shown that at the end of gastrulation, the ectoderm loses its competence to respond to endogenous neural inducers (Kintner and Dodd, 1991; Servetnick and Grainger, 1991; Sharpe and Gurdon, 1990; Streit et al., 1997; and references therein) . For these reasons, we were somewhat surprised to find that most neural genes tested required continuing suppression of BMP signaling to be expressed at this stage. A notable exception to this rule was nrp1, which became resistant to BMP4 signaling after gastrulation. Because nrp1 is a pan-neural marker, this finding may reflect that neuralization, but not regionalization, of the ectoderm is stable at the end of gastrulation. The observation that XSox3 was downregulated by BMP4 even into the tailbud stages was surprising because XSox3 is often considered a pan-neural marker and in the chick it is not suppressed by BMP4 at the end of gastrulation (Streit et al., 1998; Wilson et al., 2000) . However, at least in the frog, XSox3 is not a pan-neural marker at the neurula stage (see below and Z. Hardcastle and N. Papalopulu, unpublished results).
We also found that prechordal mesoderm, which comes to underlie anterior neuroectoderm during gastrulation, expresses high levels of BMP4 and BMP7 in the neurula embryo. Given the widespread suppression of neural genes by BMP signaling at this stage, the question arises of how neural gene expression is maintained in the anterior neural plate.
We offer two explanations to answer this question and reconcile our observations. First, it is possible that, at the neural plate stage, BMP4 signaling is completely neutralized by BMP4 inhibitors. Indeed, in Xenopus, noggin is expressed in the anterior neural plate, albeit in a narrow anterior domain (Knecht and Harland, 1997) , and chordin is expressed in the prechordal mesoderm and notochord at stage 13 (Sasai et al., 1994) . Second, it is possible that BMP4 signaling is locally neutralized and therefore suppresses neural gene expression in spatially restricted regions of the neural plate. Such localized suppression would lead to the fine-tuning of neural gene expression. Indeed, the expression of several neural genes is refined at around this time of development. For example, XSox3 is initially expressed throughout the neural ectoderm (Penzel et al., 1997) but at the neural plate stage its expression is cleared from a central region and maintained in two horseshoe stripes (Z. Hardcastle and N. Papalopulu, unpublished observations). The anterior of these two stripes overlaps with XBF-1, which in turn overlaps with, and is induced by, Noggin (Knecht and Harland, 1997; Papalopulu and Kintner, 1996) . Here, we have shown that XBF-1 suppresses BMP4 expression and prevents the ectoderm from responding to BMP4 signaling, suggesting that XBF-1 "protects" XSox3 from suppression by BMP4 signaling. XBF-2, which overlaps with the posterior XSox3 stripe, is also known to suppress BMP4 expression, although it is not known whether it also suppresses the response to BMP4 signaling (Mariani and Harland, 1998) .
Thus, the available data so far support the idea that sensitivity to BMP4 inhibition results in localized suppression of neural gene expression in areas of the neural plate that do not express BMP inhibitors. However, distinguishing with certainty between the two possibilities will require a complete knowledge of the distribution of BMP inhibitors in the anterior neural plate, especially because there may be several other neural genes that act as BMP inhibitors and/or repressors [e.g., geminin (Kroll et al., 1998 and Xiro1 (Gomez-Skarmeta et al., 2001) ].
Like XSox3, Pax-6 expression is also initially uniform in the anterior neural plate but is suppressed in a central domain during the early neurula stage. Interestingly, this Pax-6-negative domain is in register with the high level of underlying BMP4 expression (data not shown); however, in our experiments, Pax-6 was not strongly inhibited by late BMP4 signaling. Suppression of Pax-6 in the midline may depend on shh signaling (Macdonald et al., 1995; Pera and Kessel, 1997; Liem et al., 2000) .
In conclusion, we have shown that the competence of the neural ectoderm to respond to BMP signaling, as monitored by regulatory gene expression, changes to a very limited degree at the end of gastrulation. Is there a change in responsiveness to BMP signaling later in development? Although we have not addressed this question in this work, previous experiments have exposed chick and mouse neural tissue to BMP after neural tube closure. In these experiments, BF-1was inhibited, Pax-6 was reduced, and msx-1 was induced (Furuta et al., 1997; Golden et al., 1999) . These findings were interpreted with respect to dorsoventral patterning, which is difficult to do at the neural plate stage because the dorsoventral axis is not apparent before neural tube closure (Eagleson and Harris, 1990; Eagleson et al., 1995) . Comparisons may also be complicated as a result of species-specific differences. Nevertheless, it is interesting that the response of BF-1 and Pax-6 is similar to what we found in the frog neurula embryo, in that BF-1 was strongly suppressed and Pax-6 much less so. The response of msx1 is also interesting because, across species, it appears to be upregulated by BMP signaling from blastula to neural tube stages [early frog (this work; Suzuki et al., 1997; Maeda et al., 1997) ; early chicken (Streit and Stern 1999) ; late mouse (Furuta et al., 1997) ]. Interestingly, although msx1 always appears to respond positively to BMP4, the tissue specificity of msx1 expression differs during development. In early development, msx1 is a marker of epidermal ectoderm and ventrolateral mesoderm, whereas later on it is a marker of neural crest (Maeda et al., 1997; Suzuki et al., 1997) and dorsomedial forebrain (Furuta et al., 1997) . Therefore, any potential differences in the competence of the ectoderm to respond to BMP signaling during development is likely to involve changes downstream from the response of these early responsive genes.
